07/10/2026 13:45 - 14:10pm

Contributors

Paolo Ferrigno : Product Manager - Datwyler

As injections move from hospital IV infusion to self subcutaneous (SC) administration, large-volume parenteral (LVP) solutions are becoming increasingly important. This shift is driving new challenges in drug delivery, including higher viscosity formulations, larger fill volumes, and higher expectations for system performance and reliability.In this session, Datwyler experts will explore how NeoFlex LVP solutions support this transition by enabling safe and efficient delivery of sensitive biologics. 

We will highlight how optimized components help maintain drug stability while meeting the demands of next-generation SC therapies.Finally, we will show how collaboration and close partnerships can simplify complexity, reduce development risk, and accelerate time-to-market for innovative therapies with a patient-centric approach.